TREDJE AP-FONDEN – Alnylam Pharmaceuticals, Inc. Transaction History
TREDJE AP-FONDEN portfolio value:
$4.77M
portfolio value
Alnylam Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | 0.00% | 23.84K shares | 4.77M | $200.16 | 23.84K |
Q2 2018 | share | Decrease | -100.00% | -7.2K shares | -858K | $98.49 | 0 |
Q1 2018 | share | Increase | +97.26% | 3.55K shares | 394K | $119.1 | 7.2K |
Q4 2017 | share | Increase | 0.00% | 3.65K shares | 464K | $127.05 | 3.65K |